The G2 IVC filter is a blood clot filter made by C.R. Bard intended to catch clots before they enter the heart or lungs, resulting in pulmonary embolism. It is a cage-like device inserted into the largest vein of the body, the vena cava. They are mainly used in patients who cannot tolerate blood thinners.
Barry Tuttle of Ohio alleges the G2 filter proved to be life-threatening. After receiving it on Nov. 15, 2007, he alleged he received injuries connected to the device that led him to file a lawsuit against the device maker, Bard.
The G2, a similar design to the Recovery filter, which has been linked to at least 27 deaths and hundreds of injuries, was introduced in 2005 and pulled off the market five years later with no recall.
In 2004, C.R. Bard hired a private consultant named Dr. John Lehmann to study the risks of the Recovery filter, which was introduced on the market in 2005 and was pulled two years later with no recall. Dr. Lehmann’s report, now dubbed the “Lehmann Report,” concluded that the Recovery IVC filter was linked to much higher failure rates than similar models by competitors, and urged the device be investigated for fractures and migrations.
NBC News investigators dug through FDA adverse event reports and found hundreds of injuries as well as at least 12 deaths linked with the G2 filter. NBC News, in its report, pointed out that Bard knew the G2 and virtually identical G2 Express were just like the proven-to-be dangerous Recovery, and yet the company continued to sell them by the thousands. Instead of recalling the G2 and G2 Express before more injuries and deaths occurred, the company sold a total of 160,000 filters in five years.
More than 1,100 lawsuits are now pending against C.R. Bard for its allegedly dangerous and faulty IVC filters.
Source: Daily Hornet